Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as “***”. A complete version of this exhibit has been filed...License Agreement • October 13th, 2015 • Axsome Therapeutics, Inc. • Pharmaceutical preparations • New York
AXSOME THERAPEUTICS CONSULTING AGREEMENTConsulting Agreement • October 13th, 2015 • Axsome Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of April 13, 2012, (the “Effective Date”) by and between Axsome Therapeutics, Inc., a Delaware corporation having a principal place of business at 45 Rockefeller Plaza, Suite 2000, New York, NY 10111 (hereinafter referred to as the “Company”) and Mark Coleman, M.D., a physician residing at 10 Chris Elliot Court, Cockeysville, MD 21030 (hereinafter referred to as the “Consultant”).
